384 related articles for article (PubMed ID: 33470705)
1. Major gastrointestinal bleeding risk with direct oral anticoagulants: Does type and dose matter? - A systematic review and network meta-analysis.
Radadiya D; Devani K; Brahmbhatt B; Reddy C
Eur J Gastroenterol Hepatol; 2021 Dec; 33(1S Suppl 1):e50-e58. PubMed ID: 33470705
[TBL] [Abstract][Full Text] [Related]
2. Gastrointestinal Bleeding on Oral Anticoagulation: What is Currently Known.
Ingason AB; Hreinsson JP; Björnsson ES
Drug Saf; 2022 Dec; 45(12):1449-1456. PubMed ID: 36227528
[TBL] [Abstract][Full Text] [Related]
3. Direct oral anticoagulants versus warfarin in nonvalvular atrial fibrillation patients with prior gastrointestinal bleeding: a network meta-analysis of real-world data.
Hu W; Cai H; Zhang J
Eur J Clin Pharmacol; 2022 Jul; 78(7):1057-1067. PubMed ID: 35296907
[TBL] [Abstract][Full Text] [Related]
4. Oral anticoagulants for prevention of stroke in atrial fibrillation: systematic review, network meta-analysis, and cost effectiveness analysis.
López-López JA; Sterne JAC; Thom HHZ; Higgins JPT; Hingorani AD; Okoli GN; Davies PA; Bodalia PN; Bryden PA; Welton NJ; Hollingworth W; Caldwell DM; Savović J; Dias S; Salisbury C; Eaton D; Stephens-Boal A; Sofat R
BMJ; 2017 Nov; 359():j5058. PubMed ID: 29183961
[No Abstract] [Full Text] [Related]
5. Warfarin Is Associated With Higher Rates of Upper But Not Lower Gastrointestinal Bleeding Compared with Direct Oral Anticoagulants: A Population-Based Propensity-Weighted Cohort Study.
Ingason AB; Hreinsson JP; Agustsson AS; Lund SH; Rumba E; Palsson DA; Reynisson IE; Gudmundsdottir BR; Onundarson PT; Bjornsson ES
Clin Gastroenterol Hepatol; 2023 Feb; 21(2):347-357.e10. PubMed ID: 35977616
[TBL] [Abstract][Full Text] [Related]
6. The association between non-vitamin K antagonist oral anticoagulants and gastrointestinal bleeding: a meta-analysis of observational studies.
He Y; Wong IC; Li X; Anand S; Leung WK; Siu CW; Chan EW
Br J Clin Pharmacol; 2016 Jul; 82(1):285-300. PubMed ID: 26889922
[TBL] [Abstract][Full Text] [Related]
7. Rivaroxaban Is Associated With Higher Rates of Gastrointestinal Bleeding Than Other Direct Oral Anticoagulants : A Nationwide Propensity Score-Weighted Study.
Ingason AB; Hreinsson JP; Ágústsson AS; Lund SH; Rumba E; Pálsson DA; Reynisson IE; Guðmundsdóttir BR; Önundarson PT; Björnsson ES
Ann Intern Med; 2021 Nov; 174(11):1493-1502. PubMed ID: 34633836
[TBL] [Abstract][Full Text] [Related]
8. Restarting Warfarin vs Direct Oral Anticoagulants After Major Gastrointestinal Bleeding and Associated Outcomes in Atrial Fibrillation: A Cohort Study.
Tapaskar N; Ham SA; Micic D; Sengupta N
Clin Gastroenterol Hepatol; 2022 Feb; 20(2):381-389.e9. PubMed ID: 33227428
[TBL] [Abstract][Full Text] [Related]
9. Direct-acting oral anticoagulants versus warfarin in relation to risk of gastrointestinal bleeding: a systematic review and meta-analysis of randomized controlled trials.
Aloysius MM; Perisetti A; Goyal H; Boregowda U; Jecmenica M; Cheryala M; Bajaj A; Milekic B; Babic M; Bansal P; Enders GH
Ann Gastroenterol; 2021; 34(5):651-659. PubMed ID: 34475735
[TBL] [Abstract][Full Text] [Related]
10. Comparison of major bleeding risk in patients with non-valvular atrial fibrillation receiving direct oral anticoagulants in the real-world setting: a network meta-analysis.
Deitelzweig S; Farmer C; Luo X; Li X; Vo L; Mardekian J; Fahrbach K; Ashaye A
Curr Med Res Opin; 2018 Mar; 34(3):487-498. PubMed ID: 29188721
[TBL] [Abstract][Full Text] [Related]
11. Dose specific effectiveness and safety of DOACs in patients with non-valvular atrial fibrillation: A Canadian retrospective cohort study.
Rahme E; Godin R; Nedjar H; Dasgupta K; Tagalakis V
Thromb Res; 2021 Jul; 203():121-130. PubMed ID: 34000493
[TBL] [Abstract][Full Text] [Related]
12. Editor's Choice - Severe Bleeding Risks of Direct Oral Anticoagulants in the Prevention and Treatment of Venous Thromboembolism: A Network Meta-Analysis of Randomised Controlled Trials.
Chen J; Lv M; Wu S; Jiang S; Xu W; Qian J; Chen M; Fang Z; Zeng Z; Zhang J
Eur J Vasc Endovasc Surg; 2022 Mar; 63(3):465-474. PubMed ID: 34973879
[TBL] [Abstract][Full Text] [Related]
13. Management of Oral Anticoagulation Therapy After Gastrointestinal Bleeding: Whether to, When to, and How to Restart an Anticoagulation Therapy.
Kido K; Scalese MJ
Ann Pharmacother; 2017 Nov; 51(11):1000-1007. PubMed ID: 28639882
[TBL] [Abstract][Full Text] [Related]
14. Proton Pump Inhibitor Co-Therapy in Patients with Atrial Fibrillation Treated with Oral Anticoagulants and a Prior History of Upper Gastrointestinal Tract Bleeding.
Lee SR; Kwon S; Choi EK; Jung JH; Han KD; Oh S; Lip GYH
Cardiovasc Drugs Ther; 2022 Aug; 36(4):679-689. PubMed ID: 33730289
[TBL] [Abstract][Full Text] [Related]
15. Risk of gastrointestinal bleeding during anticoagulant treatment.
Lanas-Gimeno A; Lanas A
Expert Opin Drug Saf; 2017 Jun; 16(6):673-685. PubMed ID: 28467190
[TBL] [Abstract][Full Text] [Related]
16. Comparative Clinical Outcomes of Edoxaban in Adults With Nonvalvular Atrial Fibrillation.
Aronow WS; Shamliyan TA
Am J Ther; 2020; 27(3):e270-e285. PubMed ID: 30277905
[TBL] [Abstract][Full Text] [Related]
17. Risk of intracranial hemorrhage with direct oral anticoagulants: a systematic review and meta-analysis of randomized controlled trials.
Wu T; Lv C; Wu L; Chen W; Lv M; Jiang S; Zhang J
J Neurol; 2022 Feb; 269(2):664-675. PubMed ID: 33594452
[TBL] [Abstract][Full Text] [Related]
18. A systematic review of direct oral anticoagulant use in chronic kidney disease and dialysis patients with atrial fibrillation.
Feldberg J; Patel P; Farrell A; Sivarajahkumar S; Cameron K; Ma J; Battistella M
Nephrol Dial Transplant; 2019 Feb; 34(2):265-277. PubMed ID: 29509922
[TBL] [Abstract][Full Text] [Related]
19. Outcomes Associated With Resuming Direct Oral Anticoagulant Therapy Following Admission for a Gastrointestinal Bleed.
Valanejad SM; Davis KA; Nisly SA
Ann Pharmacother; 2020 Oct; 54(10):975-980. PubMed ID: 32141301
[TBL] [Abstract][Full Text] [Related]
20. Anticoagulant-related gastrointestinal bleeding: a real-life data analysis on bleeding profiles, frequency and etiology of patients receiving direct oral anticoagulants versus vitamin K antagonists.
Albrecht H; Maass LS; Hagel AF; Neurath MF; Konturek PC; Raithel M
J Physiol Pharmacol; 2019 Dec; 70(6):. PubMed ID: 32203937
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
